Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8459276 | Radiotherapy and Oncology | 2018 | 7 Pages |
Abstract
Reducing doses to all salivary glands maximizes PROMs. A cSMG dose constraint of â¤39 Gy does not increase failure risk.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Peter G. Hawkins, Jae Y. Lee, Yanping Mao, Pin Li, Michael Green, Francis P. Worden, Paul L. Swiecicki, Michelle L. Mierzwa, Matthew E. Spector, Matthew J. Schipper, Avraham Eisbruch,